March 28, 2023 Comments Off on New patent for Abbvie Inc drug VENCLEXTA Posted in: Patent Added Annual Drug Patent Expirations for VENCLEXTA Venclexta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Abbvie Inc drug VENCLEXTA appeared first on DrugPaten…
March 28, 2023 Comments Off on New patent for Am Regent drug INJECTAFER Posted in: Patent Added Annual Drug Patent Expirations for INJECTAFER Injectafer is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Am Regent drug INJECTAFER appeared first on DrugPat…